PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 214 filers reported holding PDL BIOPHARMA INC in Q1 2015. The put-call ratio across all filers is 0.29 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $1,000 | -50.0% | 352 | -47.2% | 0.00% | – |
| Q1 2020 | $2,000 | -50.0% | 667 | -51.8% | 0.00% | – |
| Q4 2019 | $4,000 | -55.6% | 1,385 | -67.4% | 0.00% | -100.0% |
| Q3 2019 | $9,000 | -10.0% | 4,246 | +35.9% | 0.00% | 0.0% |
| Q2 2019 | $10,000 | -16.7% | 3,125 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $12,000 | +50.0% | 3,125 | +6.8% | 0.00% | 0.0% |
| Q4 2018 | $8,000 | 0.0% | 2,925 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $8,000 | +166.7% | 2,925 | +111.2% | 0.00% | – |
| Q2 2018 | $3,000 | – | 1,385 | +5921.7% | 0.00% | – |
| Q4 2014 | $0 | – | 23 | 0.0% | 0.00% | – |
| Q3 2014 | $0 | – | 23 | 0.0% | 0.00% | – |
| Q2 2014 | $0 | -100.0% | 23 | -94.9% | 0.00% | -100.0% |
| Q1 2014 | $4,000 | – | 448 | +1847.8% | 0.00% | – |
| Q4 2013 | $0 | – | 23 | 0.0% | 0.00% | – |
| Q3 2013 | $0 | – | 23 | 0.0% | 0.00% | – |
| Q2 2013 | $0 | – | 23 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Argent Trust Co | 41,405 | $102,270 | 0.01% |
| Diversified Trust Co | 11,029 | $26,469 | 0.00% |
| HANCOCK WHITNEY CORP | 128,396 | $0 | 0.00% |
| RHUMBLINE ADVISERS | 612 | $1,511 | 0.00% |
| Ancora Advisors LLC | 4,948 | $0 | 0.00% |
| Westside Investment Management, Inc. | 500 | $0 | 0.00% |